1317 Enhancing patient safety in melanoma treatment: harnessing machine learning for predicting immune-related adverse events
Päätekijät: | Samir Gupta, Michael B Atkins, Neil J Shah, Jacob Zaemes, Shaked Lev Ari, Yili Zhang, Adil Alaoui, Subha Madhavan, Peter McGarvey |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
BMJ Publishing Group
2023-11-01
|
Sarja: | Journal for ImmunoTherapy of Cancer |
Samankaltaisia teoksia
-
1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan
Tekijä: Samir Gupta, et al.
Julkaistu: (2023-11-01) -
A violação de Britânico (Tac. Ann. 13.17) = Britannicus’ Rape (Tac. Ann. 13.17)
Tekijä: Nuno Simões Rodrigues
Julkaistu: (2020-11-01) -
615 The impact of gender including female menopausal status on the safety and efficacy of immune checkpoint inhibitors
Tekijä: Michael B Atkins, et al.
Julkaistu: (2023-11-01) -
A quantitative hydroclimatic context for the European Great Famine of 1315–1317
Tekijä: Seung H. Baek, et al.
Julkaistu: (2020-09-01) -
AMASYA ÂŞIK PAŞA HANKAHINDA 1317 YILI MEVLEVÎ AYİNİNİN PERDE ARKASI
Tekijä: Recep Uslu
Julkaistu: (2023-10-01)